Orthofix International | OFIX - Operating Profit

Stock Price
12.19
Daily Change
-0.25 -2.01%
Monthly
4.10%
Yearly
1.41%
Q2 Forecast
11.66

Orthofix International reported $6.12M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Stryker USD 1.1B 867M Mar/2026
Surmodics USD 58K 5.7M Jun/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Veracyte USD 19.08M 5.55M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026